Christopher B. Boyer
  • Blog
  • Publications
  • Talks
  • Teaching
  • Software

Publications

Pre-prints

  1. Jia, K.M., <strong>Boyer, C.</strong>, Bilinski, A. & Lipsitch, M. (2025). “Defining and Estimating Outcomes Directly Averted by a Vaccination Program when Rollout Occurs Over Time”. arXiv. DOI: doi.org/10.48550/arXiv.2509.05508.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/katjia/vax_rollout_impact" target="_blank">repository</a></span>
      
      
      
    </div>
  2. <strong>Boyer, C.</strong>, Field, E., Lehrer, R., Morrison, A., & Piras, C. (2025). “Guy Talk: Catalyzing Peer Effects on IPV through Virtual Support Groups for Men”. Working Paper. DOI: dx.doi.org/10.18235/0013783.

  3. Zhang, Z., <strong>Boyer, C.</strong>, Lipsitch, M. (2024). “Use of the test-negative design to estimate the protective effect of a scalar immune measure: A simulation analysis”. medRxiv. DOI: doi.org/10.1101/2024.11.22.24317757.

  4. Joshi, K., Kahn, R., <strong>Boyer, C.</strong>, & Lipsitch, M. (2023). “Some principles for using epidemiologic study results to parameterize transmission models”. medRxiv. DOI: doi.org/10.1101/2023.10.03.23296455.

No matching items

:::

  1. <strong>Boyer, C.</strong>, Li, K.Q., Shi, X., & Tchetgen Tchetgen, T. J. (2026). “Identification and estimation of vaccine effectiveness in the test-negative design under equi-confounding”. Epidemiology. 37(1), 77-87. DOI: doi.org/10.1097/EDE.0000000000001926.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.48550/arXiv.2504.20360" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/parallel-tnd" target="_blank">repository</a></span>
      
      
      
    </div>
  2. Gago, J., <strong>Boyer, C.</strong>, & Lipsitch, M. (2026). “How should we study the indirect effects of antimicrobial treatment strategies? A causal perspective”. Epidemiology. 37(1), 88-97. DOI: doi.org/10.1097/EDE.0000000000001921.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.1101/2025.03.28.25324855" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  3. <strong>Boyer, C.</strong>, Dahabreh, I. J., & Steingrimsson, J. A. (2025). “Estimating and evaluating counterfactual prediction models”. Statistics in Medicine. 44(23-24), e70287. DOI: doi.org/10.1002/sim.70287.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.48550/arXiv.2308.13026" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/validating-counterfactual-predictions" target="_blank">repository</a></span>
      
      
      
    </div>
  4. Voter, S. C., Dahabreh, I. J., <strong>Boyer, C.</strong>, Rahbar, H., Kontos, D., & Steingrimsson, J. A. (2025). “Counterfactual prediction from machine learning models: transportability and joint analysis for model development and evaluation using multi-source data”. Diagnostic and Prognostic Research. 9(22). DOI: doi.org/10.1186/s41512-025-00201-y.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/sarah-voter/counterfactual_prediction_machine_learning_paper_code" target="_blank">repository</a></span>
      
      
      
    </div>
  5. Jia, K. M., <strong>Boyer, C.</strong>, Wallinga, J., & Lipsitch, M. (2025). “Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions”. Epidemiology. 36(3), 363-373. DOI: doi.org/10.1097/EDE.0000000000001839.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/katjia/impact_estimands" target="_blank">repository</a></span>
      
      
      
    </div>
  6. <strong>Boyer, C.</strong> & Lipsitch, M. (2025). “Emulating target trials of postexposure vaccines using observational data”. American Journal of Epidemiology. 194(7), 2037-2046. DOI: doi.org/10.1093/aje/kwae350.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  7. <strong>Boyer, C.</strong>, Rumpler, E., Kissler, S. M., & Lipsitch, M. (2022). “Infectious disease dynamics and restrictions on social gathering size”. Epidemics. 40, 100620. DOI: doi.org/10.1016/j.epidem.2022.100620.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/covid-gathering-size" target="_blank">repository</a></span>
      
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong>, Paluck, E. L., Annan, J., Nevatia, T., Cooper, J., Namubiru, J, Heise, L., & Lehrer, R. (2022). “Religious leaders can motivate men to cede power and reduce intimate partner violence: experimental evidence from Uganda”. PNAS. 119(31), e2200262119. DOI: doi.org/10.1073/pnas.2200262119.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://doi.org/10.7910/DVN/9TEAIV" target="_blank">repository</a></span>
      
      
      <span style="margin-right: 10px;"><iconify-icon inline icon="carbon:plan"></iconify-icon> <a href="https://www.socialscienceregistry.org/trials/3994/history/43131" target="_blank">pre-analysis plan</a></span>
    </div>
  2. Pinchoff, J., <strong>Boyer, C.</strong>, Nag Chowdhuri, R., Smith, G., Chintu, N., & Ngo, T. D. (2019). “The evaluation of the Womans Condom marketing approach: What value did peer-led interpersonal communication add to the promotion of a new female condom in urban Lusaka?”. Plos one. 14(12), e0225832. DOI: doi.org/10.1371/journal.pone.0225832.

No matching items

:::

  1. Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., <strong>Boyer, C.</strong>, … & Rothberg, M. B. (2025). “Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status”. Obesity. 33(9), 1657-1667. DOI: doi.org/10.1002/oby.24331.

  2. Rosen, J. B., Arciuolo, R. J., Pathela, P., <strong>Boyer, C.</strong>, Baumgartner, J., Latash, J., Malec, L., Lee, E. H., Reddy, V., King, R., Edward Real, J., Lipsitch, M., & Zucker, J. R. (2024). “JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data”. Vaccine. 42(3), 548-555. DOI: doi.org/10.1016/j.vaccine.2023.12.066.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Rosen%20et%20al.%20-%202024%20-%20JYNNEOS%E2%84%A2%20effectiveness%20as%20post-exposure%20prophylaxi.pdf" target="_blank">pdf</a></span>
      
      
    </div>
  3. Chatterji, S., <strong>Boyer, C.</strong>, Sharma, V., Abramsky, T., Levtov, R., Doyle, K., Harvey, S., & Heise, L. (2023). “Optimizing the Construction of Outcome Measures for Impact Evaluations of Intimate Partner Violence Prevention Interventions”. Journal of Interpersonal Violence. 38(15-16), 9105-9131. DOI: doi.org/10.1177/08862605231162887.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2023.02.07.23285510.abstract" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  4. NCD Risk Factor Collaboration (NCD-RisC). (2021). “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants”. The Lancet. 398(10304), 957-980. DOI: doi.org/10.1016/S0140-6736(21)01330-1.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Zhou%20et%20al.%20-%202021%20-%20Worldwide%20trends%20in%20hypertension%20prevalence%20and%20pr.pdf" target="_blank">pdf</a></span>
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong> (2023). “New approaches to factual and counterfactual prediction modeling”. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf" target="_blank">pdf</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="file-icons:keynote"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf">slides</a></span>
      
    </div>
No matching items

:::

:::

Peer-reviewed publications

Methodological

  1. <strong>Boyer, C.</strong>, Li, K.Q., Shi, X., & Tchetgen Tchetgen, T. J. (2026). “Identification and estimation of vaccine effectiveness in the test-negative design under equi-confounding”. Epidemiology. 37(1), 77-87. DOI: doi.org/10.1097/EDE.0000000000001926.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.48550/arXiv.2504.20360" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/parallel-tnd" target="_blank">repository</a></span>
      
      
      
    </div>
  2. Gago, J., <strong>Boyer, C.</strong>, & Lipsitch, M. (2026). “How should we study the indirect effects of antimicrobial treatment strategies? A causal perspective”. Epidemiology. 37(1), 88-97. DOI: doi.org/10.1097/EDE.0000000000001921.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.1101/2025.03.28.25324855" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  3. <strong>Boyer, C.</strong>, Dahabreh, I. J., & Steingrimsson, J. A. (2025). “Estimating and evaluating counterfactual prediction models”. Statistics in Medicine. 44(23-24), e70287. DOI: doi.org/10.1002/sim.70287.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://doi.org/10.48550/arXiv.2308.13026" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/validating-counterfactual-predictions" target="_blank">repository</a></span>
      
      
      
    </div>
  4. Voter, S. C., Dahabreh, I. J., <strong>Boyer, C.</strong>, Rahbar, H., Kontos, D., & Steingrimsson, J. A. (2025). “Counterfactual prediction from machine learning models: transportability and joint analysis for model development and evaluation using multi-source data”. Diagnostic and Prognostic Research. 9(22). DOI: doi.org/10.1186/s41512-025-00201-y.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/sarah-voter/counterfactual_prediction_machine_learning_paper_code" target="_blank">repository</a></span>
      
      
      
    </div>
  5. Jia, K. M., <strong>Boyer, C.</strong>, Wallinga, J., & Lipsitch, M. (2025). “Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions”. Epidemiology. 36(3), 363-373. DOI: doi.org/10.1097/EDE.0000000000001839.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/katjia/impact_estimands" target="_blank">repository</a></span>
      
      
      
    </div>
  6. <strong>Boyer, C.</strong> & Lipsitch, M. (2025). “Emulating target trials of postexposure vaccines using observational data”. American Journal of Epidemiology. 194(7), 2037-2046. DOI: doi.org/10.1093/aje/kwae350.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  7. <strong>Boyer, C.</strong>, Rumpler, E., Kissler, S. M., & Lipsitch, M. (2022). “Infectious disease dynamics and restrictions on social gathering size”. Epidemics. 40, 100620. DOI: doi.org/10.1016/j.epidem.2022.100620.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2022.01.07.21268585v2" target="_blank">pre-print</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://github.com/boyercb/covid-gathering-size" target="_blank">repository</a></span>
      
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong>, Paluck, E. L., Annan, J., Nevatia, T., Cooper, J., Namubiru, J, Heise, L., & Lehrer, R. (2022). “Religious leaders can motivate men to cede power and reduce intimate partner violence: experimental evidence from Uganda”. PNAS. 119(31), e2200262119. DOI: doi.org/10.1073/pnas.2200262119.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://doi.org/10.7910/DVN/9TEAIV" target="_blank">repository</a></span>
      
      
      <span style="margin-right: 10px;"><iconify-icon inline icon="carbon:plan"></iconify-icon> <a href="https://www.socialscienceregistry.org/trials/3994/history/43131" target="_blank">pre-analysis plan</a></span>
    </div>
  2. Pinchoff, J., <strong>Boyer, C.</strong>, Nag Chowdhuri, R., Smith, G., Chintu, N., & Ngo, T. D. (2019). “The evaluation of the Womans Condom marketing approach: What value did peer-led interpersonal communication add to the promotion of a new female condom in urban Lusaka?”. Plos one. 14(12), e0225832. DOI: doi.org/10.1371/journal.pone.0225832.

No matching items

:::

  1. Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., <strong>Boyer, C.</strong>, … & Rothberg, M. B. (2025). “Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status”. Obesity. 33(9), 1657-1667. DOI: doi.org/10.1002/oby.24331.

  2. Rosen, J. B., Arciuolo, R. J., Pathela, P., <strong>Boyer, C.</strong>, Baumgartner, J., Latash, J., Malec, L., Lee, E. H., Reddy, V., King, R., Edward Real, J., Lipsitch, M., & Zucker, J. R. (2024). “JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data”. Vaccine. 42(3), 548-555. DOI: doi.org/10.1016/j.vaccine.2023.12.066.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Rosen%20et%20al.%20-%202024%20-%20JYNNEOS%E2%84%A2%20effectiveness%20as%20post-exposure%20prophylaxi.pdf" target="_blank">pdf</a></span>
      
      
    </div>
  3. Chatterji, S., <strong>Boyer, C.</strong>, Sharma, V., Abramsky, T., Levtov, R., Doyle, K., Harvey, S., & Heise, L. (2023). “Optimizing the Construction of Outcome Measures for Impact Evaluations of Intimate Partner Violence Prevention Interventions”. Journal of Interpersonal Violence. 38(15-16), 9105-9131. DOI: doi.org/10.1177/08862605231162887.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2023.02.07.23285510.abstract" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  4. NCD Risk Factor Collaboration (NCD-RisC). (2021). “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants”. The Lancet. 398(10304), 957-980. DOI: doi.org/10.1016/S0140-6736(21)01330-1.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Zhou%20et%20al.%20-%202021%20-%20Worldwide%20trends%20in%20hypertension%20prevalence%20and%20pr.pdf" target="_blank">pdf</a></span>
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong> (2023). “New approaches to factual and counterfactual prediction modeling”. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf" target="_blank">pdf</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="file-icons:keynote"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf">slides</a></span>
      
    </div>
No matching items

:::

:::

Publications – Christopher B. Boyer Publications – Christopher B. Boyer Publications – Christopher B. Boyer Christopher B. Boyer Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics. Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics.

Randomized Trials

  1. <strong>Boyer, C.</strong>, Paluck, E. L., Annan, J., Nevatia, T., Cooper, J., Namubiru, J, Heise, L., & Lehrer, R. (2022). “Religious leaders can motivate men to cede power and reduce intimate partner violence: experimental evidence from Uganda”. PNAS. 119(31), e2200262119. DOI: doi.org/10.1073/pnas.2200262119.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa6-brands:github"></iconify-icon> <a href="https://doi.org/10.7910/DVN/9TEAIV" target="_blank">repository</a></span>
      
      
      <span style="margin-right: 10px;"><iconify-icon inline icon="carbon:plan"></iconify-icon> <a href="https://www.socialscienceregistry.org/trials/3994/history/43131" target="_blank">pre-analysis plan</a></span>
    </div>
  2. Pinchoff, J., <strong>Boyer, C.</strong>, Nag Chowdhuri, R., Smith, G., Chintu, N., & Ngo, T. D. (2019). “The evaluation of the Womans Condom marketing approach: What value did peer-led interpersonal communication add to the promotion of a new female condom in urban Lusaka?”. Plos one. 14(12), e0225832. DOI: doi.org/10.1371/journal.pone.0225832.

No matching items

:::

  1. Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., <strong>Boyer, C.</strong>, … & Rothberg, M. B. (2025). “Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status”. Obesity. 33(9), 1657-1667. DOI: doi.org/10.1002/oby.24331.

  2. Rosen, J. B., Arciuolo, R. J., Pathela, P., <strong>Boyer, C.</strong>, Baumgartner, J., Latash, J., Malec, L., Lee, E. H., Reddy, V., King, R., Edward Real, J., Lipsitch, M., & Zucker, J. R. (2024). “JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data”. Vaccine. 42(3), 548-555. DOI: doi.org/10.1016/j.vaccine.2023.12.066.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Rosen%20et%20al.%20-%202024%20-%20JYNNEOS%E2%84%A2%20effectiveness%20as%20post-exposure%20prophylaxi.pdf" target="_blank">pdf</a></span>
      
      
    </div>
  3. Chatterji, S., <strong>Boyer, C.</strong>, Sharma, V., Abramsky, T., Levtov, R., Doyle, K., Harvey, S., & Heise, L. (2023). “Optimizing the Construction of Outcome Measures for Impact Evaluations of Intimate Partner Violence Prevention Interventions”. Journal of Interpersonal Violence. 38(15-16), 9105-9131. DOI: doi.org/10.1177/08862605231162887.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2023.02.07.23285510.abstract" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  4. NCD Risk Factor Collaboration (NCD-RisC). (2021). “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants”. The Lancet. 398(10304), 957-980. DOI: doi.org/10.1016/S0140-6736(21)01330-1.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Zhou%20et%20al.%20-%202021%20-%20Worldwide%20trends%20in%20hypertension%20prevalence%20and%20pr.pdf" target="_blank">pdf</a></span>
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong> (2023). “New approaches to factual and counterfactual prediction modeling”. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf" target="_blank">pdf</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="file-icons:keynote"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf">slides</a></span>
      
    </div>
No matching items

:::

:::

Publications – Christopher B. Boyer Publications – Christopher B. Boyer Publications – Christopher B. Boyer Christopher B. Boyer Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics. Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics.

Applied/Collaborative

  1. Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., <strong>Boyer, C.</strong>, … & Rothberg, M. B. (2025). “Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status”. Obesity. 33(9), 1657-1667. DOI: doi.org/10.1002/oby.24331.

  2. Rosen, J. B., Arciuolo, R. J., Pathela, P., <strong>Boyer, C.</strong>, Baumgartner, J., Latash, J., Malec, L., Lee, E. H., Reddy, V., King, R., Edward Real, J., Lipsitch, M., & Zucker, J. R. (2024). “JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data”. Vaccine. 42(3), 548-555. DOI: doi.org/10.1016/j.vaccine.2023.12.066.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Rosen%20et%20al.%20-%202024%20-%20JYNNEOS%E2%84%A2%20effectiveness%20as%20post-exposure%20prophylaxi.pdf" target="_blank">pdf</a></span>
      
      
    </div>
  3. Chatterji, S., <strong>Boyer, C.</strong>, Sharma, V., Abramsky, T., Levtov, R., Doyle, K., Harvey, S., & Heise, L. (2023). “Optimizing the Construction of Outcome Measures for Impact Evaluations of Intimate Partner Violence Prevention Interventions”. Journal of Interpersonal Violence. 38(15-16), 9105-9131. DOI: doi.org/10.1177/08862605231162887.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa:pencil"></iconify-icon> <a href="https://www.medrxiv.org/content/10.1101/2023.02.07.23285510.abstract" target="_blank">pre-print</a></span>
      
      
      
      
    </div>
  4. NCD Risk Factor Collaboration (NCD-RisC). (2021). “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants”. The Lancet. 398(10304), 957-980. DOI: doi.org/10.1016/S0140-6736(21)01330-1.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="files/Zhou%20et%20al.%20-%202021%20-%20Worldwide%20trends%20in%20hypertension%20prevalence%20and%20pr.pdf" target="_blank">pdf</a></span>
      
      
    </div>
No matching items

:::

  1. <strong>Boyer, C.</strong> (2023). “New approaches to factual and counterfactual prediction modeling”. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf" target="_blank">pdf</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="file-icons:keynote"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf">slides</a></span>
      
    </div>
No matching items

:::

:::

Publications – Christopher B. Boyer Publications – Christopher B. Boyer Publications – Christopher B. Boyer Christopher B. Boyer Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics. Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics.

Dissertation

  1. <strong>Boyer, C.</strong> (2023). “New approaches to factual and counterfactual prediction modeling”. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.

      <span style="margin-right: 10px;"><iconify-icon inline icon="fa-regular:file-pdf"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf" target="_blank">pdf</a></span>
      <span style="margin-right: 10px;"><iconify-icon inline icon="file-icons:keynote"></iconify-icon> <a href="https://dash.harvard.edu/bitstream/handle/1/37374603/thesis.pdf">slides</a></span>
      
    </div>
No matching items

:::

:::

Publications – Christopher B. Boyer Publications – Christopher B. Boyer Publications – Christopher B. Boyer Christopher B. Boyer Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics. Personal website of Christopher B. Boyer, Assistant Professor at Cleveland Clinic specializing in causal inference and biostatistics.